References
Medawar PB: The behavior and fate of skin autografts and homografts in rabbits. J Anat 1944; 78: 176–199.
Manning DD, Reed ND, Shaffer CF: Maintenance of skin xenografts of widely divergent phylogenetic origin on congenitally athymic (nude) mice. J Exp M 1973; 138: 488.
Chen CMC, Tsai LC, Chung CF, et al: Survival times of skin xenografts in mice under chronic treatment with antithymocyte serum in different dosage-timing schedules. Transplantation 1971: 12: 157.
Winn HJ: Antibody mediated rejection: in Williams GM, Burdick JF, Solez K (eds): Kidney Transplant Rejection. New York, Dekker, 1986.
Mason DW, Dallman MJ, Arthur RP, et al: Mechanisms of allograft rejection: the roles of cytotoxic T-cells and delayed-type hypersensitivity. Immunol Rev 1984; 77: 177.
McKenzie IFC: Alloaggression. Transplant Proc 1983; 15: 269–273.
Hall, B, Dorsch S: Cells mediating allograft rejection. Immunol Rev 1984; 77: 570.
LeFrançois L, Bevan MJ: A reexamination of the role of Lyt-2-positive T cells in murine skin graft rejection. J Exp Med 1984; 159: 57–67.
Loveland BE, Hogarth PM, Ceredig R, et al: Cells mediate graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med 1981; 153: 1044–1057.
Steinmuller D: Which T cells mediate allograft rejection? Transplantation 1985; 40: 229–233.
Tyler JD, Galli SJ, Snider ME, et al: Cloned Lyt-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo. J Exp Med 1984; 159: 234–243.
Mintz B, Silvers WK: Intrinsic' immunological tolerance in allophenic mice. Science 1967; 158: 1484–1486.
Dialynas DP, Quan ZS, Wall KA, et al: Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal Ab GK 1.5: similarity of the L3T4 molecule to the human Leu-3/T4 molecule. J Immunol 1983; 131: 2445.
Bailey DW, Kohn HI: Inherited histocompatibility changes in progeny of irradiated and unirradiated inbred mice. Genet Res 1965; 6: 330.
Melvold RW, Kohn HI, Dunn GR: History and genealogy of the H-2Kb mutants from the C57BL/6h colony. Immunogenetics 1982; 15: 177–185.
MacKenzie IFC, Morgan GM, Sandrin MS, et al: B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med 1979; 150: 1323–1338.
Rosenberg A, Mizuochi T, Singer A: Analyses of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC. Nature 1986; 322: 829–831.
Rosenberg AS, Mizuochi T, Sharrow SO, et al: Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med 1987; 165: 1296.
Sprent J, Schaefer M, Lo D, et al: Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 1986; 163: 998–1011.
Cobbold SP, Jayasuriya A, Nash A, et al: Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 1984; 312: 548–551.
Cobold S, Waldmann H: Skin allograft rejection by L3T4+ and Lyt-2+ T cell subsets. Transplantation 1986; 41: 634–639.
Ichikawa T, Nakayama E, Uenaka A, et al: Effector cells in allelic H-2 class I-incompatible skin graft rejection. J Exp Med 1987; 166: 982–990.
Woodcock J, Wofsy D, Eriksson E, et al: Rejection of skin grafts and generation of cytotoxic T cells by mice depeleted of L3T4+ cells. Transplantation 1986; 42: 636–642.
Smith DM, Stuart FP, Wemhoff GA, et al: Cellular Pathways for rejection of class-I-MHC-disparate skin and tumor allografts. Transplantation 1988; 45: 168–175.
Wheelahan J, McKenzie IFC: The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse. Transplantation 1987; 44: 273–280.
Mottram PL, Wheelahan J, McKenzie IFC, et al: Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies. Transplant Proc 1987; 19: 2898–2901.
Cosimi AB, Burton RC, Colvin RB, et al: Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 1981; 32:535–539.
Delmonico FL, Cosimi AB: Monoclonal antibody treatment of human allograft recipients. Surg Gynecol Obstet 1988; 166: 89–98.
Ghobrial RRM, Boublick M, Fuller TC, et al: In vivo use of monoclonal antibodies against murine T cell antigens (in preparation).
Gutstein NL, Wofsy D: Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells. J Immunol 1986; 137: 3414–3419.
Auchincloss H Jr, Ghobrial RRM, Russell PS, et al: Anti-L3T4 in vivo prevents alloantibody formation after skin grafting without prolonging graft survival. Transplantation 1988; 45: 1118.
Korngold R, Sprent J: Variable capacity of L3T4+ cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med 1987; 165: 1552–1564.
Golding H, Mizuochi T, McCarthy SA, et al: Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. J Immunol 1987; 138: 10–17.
Mizuochi T, Golding H, Rosenberg AS, et al: Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogeneic major histocompatibility antigens but not against trinitrophenyl-modified self. J Exp Med 1985; 162: 427–443.
Mizuochi T, Munitz TI, McCarthy S, et al: Differential helper and effector responses of Lyt-2 T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness. J Immunol 1986; 137: 2740–2747.
Mizuochi T, Ono S, Malek TR, et al: Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens. J Exp Med 1986; 163: 603–619.
Caughman SW, Sharrow SO, Shimad S, et al: Ia+ murine epidermal Langerhans cells are deficient in surface expression of class I MHC. Proc Natl Sci USA 1986; 83: 7438–7442.
Yamaga KM, Pfaffenbach GM, Pease LR, et al: Immunochemical studies of H-2K antigens from a group of related mutants. II. Identification of a shared mutation in B6-H-2bm6, B6.C-H-2bm7, and B6.C-H-2bm9. Immunogenetics; 1983: 17: 31–41.
Chen H-D, Silvers WK: Influence of Langerhans cells on the survival of H-Y incompatible skin grafts in rats. J Invest Dermatol 1983; 81: 20–23.
Madsen JC, Peugh WN, Wood KJ, et al: The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 1987; 44: 849–852.
Hurne M, Hetherington CM, Simpson E: Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts. J Exp Med 1978; 147: 768–775.
Simpson E: The role of H-Y as a minor transplantation antigen. Immunol Today 1982; 3: 97–106.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Auchincloss, H., Mayer, T., Ghobrial, R. et al. T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection. Immunol Res 8, 149–164 (1989). https://doi.org/10.1007/BF02919076
Issue Date:
DOI: https://doi.org/10.1007/BF02919076